We are live on ! Find out more
RLAY icon

Relay Therapeutics
RLAY

115 hedge funds and large institutions have $3.64B invested in Relay Therapeutics in 2020 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 11

60% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 20

22% more funds holding

Funds holding: 94 → 115 (+21)

0% more funds holding in top 10

Funds holding in top 10: 11 → 11 (0)

0% less capital invested

Capital invested by funds: $3.64B → $3.64B (-$155K)

2.91% less ownership

Funds ownership: 100.36% → 97.46% (-2.9%)

Holders
115
Holders Change
+21
Holders Change %
+22.34%
% of All Funds
2.03%
Holding in Top 10
11
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.19%
New
32
Increased
32
Reduced
20
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$49.3M
2
State Street
State Street
Massachusetts
+$38.4M
3
Goldman Sachs
Goldman Sachs
New York
+$26.3M
4
UBS AM
UBS AM
Illinois
+$10.4M
5
Norges Bank
Norges Bank
Norway
+$9.45M

Top Sellers

Rank Fund Capital Flow
1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$252M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$17.6M
3
BI
BVF Inc
California
-$13.8M
4
EAM
Eventide Asset Management
Massachusetts
-$10.6M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$9.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACA
26
Avoro Capital Advisors
New York
$20.8M – – –
UBS AM
27
UBS AM
Illinois
$20.1M +$10.4M +229,886 +90%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$18.5M +$409K +9,042 +2%
RSCM
29
Rock Springs Capital Management
Maryland
$17.1M -$75.7K -1,674 -0.4%
AG
30
Artal Group
Luxembourg
$16.6M – – –
FCMV
31
Foresite Capital Management V
California
$16.6M +$18.1M +400,000 New
Northern Trust
32
Northern Trust
Illinois
$14.8M -$97.9K -2,165 -0.6%
O
33
OrbiMed
New York
$14.5M – – –
ACH
34
ArrowMark Colorado Holdings
Colorado
$14.1M -$211K -4,677 -1%
WP
35
Woodline Partners
California
$12.2M -$2.65M -58,608 -17%
Norges Bank
36
Norges Bank
Norway
$8.69M +$9.45M +209,085 New
FIM
37
Fernwood Investment Management
Massachusetts
$6.88M – – –
GC
38
Grace Capital
Massachusetts
$6.83M – – –
Charles Schwab
39
Charles Schwab
California
$6.63M +$204K +4,520 +3%
Wellington Management Group
40
Wellington Management Group
Massachusetts
$5.97M -$3.49M -77,257 -35%
MCM
41
Moore Capital Management
New York
$5.41M +$5.88M +130,162 New
Morgan Stanley
42
Morgan Stanley
New York
$5.35M +$1.1M +24,434 +23%
N
43
Nuveen
North Carolina
$5.35M +$120K +2,652 +2%
American Century Companies
44
American Century Companies
Missouri
$4.83M -$329K -7,275 -6%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$4.81M +$1.21M +26,801 +30%
TG
46
TCW Group
California
$4.49M -$1.53M -33,793 -24%
Janus Henderson Group
47
Janus Henderson Group
United Kingdom
$4.08M -$17.6M -388,519 -80%
IC
48
Iconiq Capital
California
$3.94M – – –
Baillie Gifford & Co
49
Baillie Gifford & Co
United Kingdom
$3.32M -$252M -5,584,989 -99%
RCM
50
Ratan Capital Management
Florida
$2.91M – – –
1
2
3 4 5

RLAY Hedge Fund Activity: Q4 2020 in Review

115 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Relay Therapeutics (RLAY) for Q4 2020, worth a combined $3.64B — down 0% from $3.64B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new RLAY positions and 11 closed out — a net gain of 21 holders — while 32 added to existing stakes and 20 trimmed.

The largest buyer was BlackRock, adding an estimated $49.3M. The largest seller was Baillie Gifford & Co, cutting an estimated $252M.

  • 115 institutional investors held Relay Therapeutics (RLAY) as of Q4 2020, up from 94 in Q3 2020.
  • Funds reported $3.64B of Relay Therapeutics stock for Q4 2020, down 0% quarter-over-quarter.
  • 32 funds opened new Relay Therapeutics positions in Q4 2020 and 11 closed out, a net change of +21 holders.
  • The largest Relay Therapeutics buyer in Q4 2020 was BlackRock, an estimated $49.3M added.
  • The largest Relay Therapeutics seller in Q4 2020 was Baillie Gifford & Co, an estimated $252M sold.

Based on aggregated 13F filings for Q4 2020.